Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification
Isabelle Fournier(The University of Texas MD Anderson Cancer Center), Jean‐Pascal Gimeno(Onco Lille), Fahed Zaïri(Inserm), Marie Duhamel(Inserm), Michel Salzet(Laboratoire Pluridisciplinaire de Recherche en Ingénierie des Systèmes, Mécanique et Energétique), Nicolas Reyns(Centre National de la Recherche Scientifique), Fabienne Escande(Université de Lille), Maxence Wisztorski(Inserm), Claude‐Alain Maurage(Centre Hospitalier Universitaire de Lille), Firas Kobeissy(Allen Institute for Brain Science)
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
November 24, 2016
Cited by 43
Related Papers
Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy
|The American Journal of Human Genetics|2016|454
French guidelines on stereoelectroencephalography (SEEG)
|Neurophysiologie Clinique|2017|348
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
|Molecular Psychiatry|2009|203
Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats
|Molecular & Cellular Proteomics|2006|182
Predictors of functional outcomes and recurrence of chronic subdural hematomas
|Journal of Clinical Neuroscience|2015|130